OBJECTIVE: We evaluated the effects of targeted, moderate endurance training on healthcare cost, body composition and fitness in type 2 diabetes patients routinely followed within the French healthcare system. DESIGN AND METHODS: A total of 25 type 2 diabetic patients was randomly assigned to one of two groups: 13 underwent a training programme (eight sessions, followed by training twice a week for 30-45 minutes at home at the level of the ventilatory threshold [V(T)]); and 12 received their usual routine treatment. Both groups were followed for one year to evaluate healthcare costs, exercise effectiveness and a six-minute walking test. RESULTS: The training prevented loss of maximum aerobic capacity, which decreased slightly in the untrained group (P=0.014), and resulted in a higher maximum power output (P=0.041) and six-minute walking distance (P=0.020). The Voorrips activity score correlated with both V(O2max) (r=0.422, P<0.05) and six-minute walking distance (r=0.446, P<0.05). Changes in V(O2max) were negatively correlated with changes in body weight (r=0.608, P<0.01). Training decreased the insulin-resistance index (HOMA-IR) by 26% (P<0.05). Changes in percentages of fat were correlated to changes in waist circumference (r=0.436, P<0.05). The total healthcare cost was reduced by 50% in the trained group (euro 1.65+/-1 per day versus euro 3.00+/-1.47 per day in the untrained group; P<0.02) due to fewer hospitalizations (P=0.05) and less use of sulphonylureas (P<0.05). CONCLUSION:Endurance training at V(T) level prevented the decline in aerobic working capacity seen in untrained diabetics over the study period, and resulted in a marked reduction in healthcare costs due to less treatments and fewer hospitalizations.
RCT Entities:
OBJECTIVE: We evaluated the effects of targeted, moderate endurance training on healthcare cost, body composition and fitness in type 2 diabetespatients routinely followed within the French healthcare system. DESIGN AND METHODS: A total of 25 type 2 diabeticpatients was randomly assigned to one of two groups: 13 underwent a training programme (eight sessions, followed by training twice a week for 30-45 minutes at home at the level of the ventilatory threshold [V(T)]); and 12 received their usual routine treatment. Both groups were followed for one year to evaluate healthcare costs, exercise effectiveness and a six-minute walking test. RESULTS: The training prevented loss of maximum aerobic capacity, which decreased slightly in the untrained group (P=0.014), and resulted in a higher maximum power output (P=0.041) and six-minute walking distance (P=0.020). The Voorrips activity score correlated with both V(O2max) (r=0.422, P<0.05) and six-minute walking distance (r=0.446, P<0.05). Changes in V(O2max) were negatively correlated with changes in body weight (r=0.608, P<0.01). Training decreased the insulin-resistance index (HOMA-IR) by 26% (P<0.05). Changes in percentages of fat were correlated to changes in waist circumference (r=0.436, P<0.05). The total healthcare cost was reduced by 50% in the trained group (euro 1.65+/-1 per day versus euro 3.00+/-1.47 per day in the untrained group; P<0.02) due to fewer hospitalizations (P=0.05) and less use of sulphonylureas (P<0.05). CONCLUSION: Endurance training at V(T) level prevented the decline in aerobic working capacity seen in untrained diabetics over the study period, and resulted in a marked reduction in healthcare costs due to less treatments and fewer hospitalizations.
Authors: C Fatone; M Guescini; S Balducci; S Battistoni; A Settequattrini; R Pippi; L Stocchi; M Mantuano; V Stocchi; P De Feo Journal: J Endocrinol Invest Date: 2010-02-05 Impact factor: 4.256
Authors: Gian Pietro Emerenziani; Maria Chiara Gallotta; Marco Meucci; Luigi Di Luigi; Silvia Migliaccio; Lorenzo Maria Donini; Felice Strollo; Laura Guidetti Journal: Int J Endocrinol Date: 2015-05-18 Impact factor: 3.257
Authors: Charlotte Lanhers; Guillaume Walther; Robert Chapier; Bruno Lesourd; Geraldine Naughton; Bruno Pereira; Martine Duclos; Agnès Vinet; Philippe Obert; Daniel Courteix; Frédéric Dutheil Journal: BMJ Open Date: 2017-04-16 Impact factor: 2.692
Authors: Gian Pietro Emerenziani; Maria Chiara Gallotta; Silvia Migliaccio; Emanuela A Greco; Chiara Marocco; Luca di Lazzaro; Rachele Fornari; Andrea Lenzi; Carlo Baldari; Laura Guidetti Journal: Int J Endocrinol Date: 2016-01-14 Impact factor: 3.257
Authors: Robert Rozenberg; Robert T Mankowski; Luc J C van Loon; Janneke G Langendonk; Eric J G Sijbrands; Anton H van den Meiracker; Henk J Stam; Stephan F E Praet Journal: Eur J Med Res Date: 2016-01-08 Impact factor: 2.175